Humira Takes Nearly 20% Of Enbrel Share; Abbott Eyes Psoriasis Market Next
Executive Summary
Abbott sees psoriasis as the next large market opportunity for Humira after rheumatoid arthritis, Immunology General Manager Tim Walbert said during Abbott's R&D Day in New York May 29